PARRY, ROMANI, DECONCINI & SYMMS ON BEHALF OF US COMPOUNDING PHARMACY

Lobbying Spend

—

Filings

Firms Hired

Active Period

2019

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2019	—	5	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
MS. TAMI WAHL	—	5

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	3
SENATE	3
Food & Drug Administration (FDA)	2
Justice, Dept of (DOJ)	2
White House Office	2

Most frequently reported lobbying issues

PARRY, ROMANI, DECONCINI & SYMMS ON BEHALF OF US COMPOUNDING PHARMACY — Lobbying Disclosure | Poliscope